M&W Foundation
M&W FoundationMicro donations. Working devices.
Impact

Visible results for the organizations that must raise the next dollar.

M&W Foundation is built to help large non-profits move faster. The outcomes below describe what the model is designed to do. Anticipated deployment ranges are labeled as such. This page does not invent completed clinic counts or testimonials.

Wide view of the humanitarian prototype workshop
A working bench, not a slide deck

Speed

Shortens the wait for R&D and prototypes

Large organizations no longer have to wait months or years for initial prototypes and testing. Focused micro-funding delivers working proof-of-concept devices.

Evidence

Proof of concept with small in-field tests

Deployments of 10 to 50 units in real conditions generate credible data and consented stories that de-risk larger investments and scale decisions.

Trust

Donors see immediate results

Supporters witness a donation turning into tangible prototypes and field work, which builds confidence for future giving.

Fundraising

Makes large campaigns easier to open

With proven concepts, real data, and visible stories in hand, partner non-profits are better positioned to secure major grants and donations.

Anticipated, not claimed as complete

Planning ranges for deployments

The original Foundation model published these as anticipated impact. They are planning ranges, not audited results.

Year 120–100 devices deployed to clinics and refugee settings in target regions
Years 2–31,000+ units via scaled production, if proof holds
Long-termDocumented access, partner confidence, and continued donation or licensed production
MeasureField feedback, outcome data, consented stories — not slogans
Health improvements such as reduced infection rates or better mobility are the kinds of outcomes the model seeks to measure after field trials. They are not presented here as already proven across a published dataset.

For researchers and partners

Come for the method. Stay for the evidence you help collect.

If you need a first device, a small-batch trial, or a co-authored impact template, start with a partnership inquiry. Agreement drafts are available for review. A thirty-minute call is the next step.

Partners examining a compact medical prototype together
Method, then evidence